Author information from the last article
E-post: trygve.holmoy@medisin.uio.no
Trygve Holmøy er seksjonsoverlege ved Akershus universitetssykehus og professor ved Universitetet i Oslo.
Articles by Trygve Holmøy
'Assisting their orphaned children when in need'
- Trygve Holmøy
18.03.2024:
On the ninth of March 1872, district medical officer Jonas Collin Boye died at Frosta from scarlet fever and typhoid. He had contracted these diseases in the line of duty. On his deathbed he was nursed by his wife, who had given birth to their sixth child four days before her husband passed away...
Norwegian health service should offer stem cell therapy for multiple sclerosis
- Gro Owren Nygaard,
- Trygve Holmøy
12.02.2024:
Many Norwegian patients with multiple sclerosis choose to travel abroad for stem cell therapy at their own expense and risk. Based on the current knowledge base, selected patients should now be offered this therapy in Norway. High-dose chemotherapy with autologous stem cell support (HDT) is not part...
Breastfeeding and treatment for multiple sclerosis
- Øivind Torkildsen,
- Brit Ellen Rød,
- Lars Bø,
- Stig Wergeland,
- Trygve Holmøy,
- Kjell-Morten Myhr
24.10.2022:
Monoclonal antibody therapy is effective for multiple sclerosis, and only small amounts of antibodies are transferred to breast milk. Even though the approved product descriptions advise against breastfeeding during medicinal treatment, several of the most effective MS drugs are compatible with...
A woman in her fifties with progressive walking difficulties
- Amanuel Hassen Ali,
- Helle Høyer,
- Eyvind Rugland,
- Trygve Holmøy
08.08.2022:
A woman in her fifties developed gradually increasing unsteadiness and weakness in her legs. Clinical investigation raised suspicion of an immunological disorder. However, immunomodulatory therapy had no effect. Further investigation two and a half years after the initial contact with a doctor...
A woman in her forties with unilateral blurred vision and pain upon eye movement
- Gorm Pihl-Jensen,
- Eva Meling Ødegaard,
- Karoline Skogen,
- Øystein Kalsnes Jørstad,
- Trygve Holmøy
03.06.2021:
A woman in her forties presented with subacute onset of unilateral blurred vision with pain upon eye movement. Although findings from MRI and cerebrospinal fluid analysis were typical of demyelinating disease, the final diagnosis was a condition requiring an entirely different therapeutic approach...
Ventilation of patients with amyotrophic lateral sclerosis
- Ole-Bjørn Tysnes,
- Trygve Holmøy,
- Solfrid Indrekvam,
- Ove Fondenæs
14.05.2021:
Just under 10 % of patients with amyotrophic lateral sclerosis receive life-prolonging ventilation via a tracheostomy. There is no international consensus on the planning of life-prolonging invasive ventilation for patients with this disease. The annual incidence rate of amyotrophic lateral...
Disease-modifying therapy for multiple sclerosis
- Trygve Holmøy,
- Gro Owren Nygaard,
- Kjell-Morten Myhr,
- Lars Bø
10.05.2021:
High-efficacy therapy from the time of diagnosis substantially improves the prognosis for multiple sclerosis. The national guidelines on MS nevertheless recommend less effective therapy for many patients, and must be updated in pace with medical advances. We consider in the following how multiple...
The first Norwegian doctorate in multiple sclerosis
- Trygve Holmøy,
- Øystein Kalsnes Jørstad
22.03.2021:
The story of research on multiple sclerosis in Norway starts in 1945 at a private Catholic hospital in the town of Hamar, where the ophthalmologist Marius Haarr was treating patients with retinal periphlebitis and neurological symptoms. He completed his doctoral degree while raising two young...